Search
for
Sort by
Research 331–360 of 1000+
- NANOEMULGEL AS A RECENT DRUG DELIVERY SYSTEM
- Association Between Gender and Drug Cost for Over-the-Counter Minoxidil
- SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATION
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Hepatotoxicity Secondary to A Drug to Lose Weight, "Orlistat": to take into Account as a Differential Diagnosis
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Androgenetic alopecia; drug safety and therapeutic strategies
- Novel causes of drug-induced occupational asthma
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- Impact of Chemotherapeutic Drug on People living with Cancer
- A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
- Ablative Fractional Resurfacing in Topical Drug Delivery: An Update and Outlook
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- Novel therapies for alopecia areata: The era of rational drug development
- Influence of Saw palmetto and Pygeum africana extracts on the urinary concentrations of endogenous anabolic steroids: Relevance to doping analysis
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Protective effect of Korean Red Ginseng against chemotherapeutic drug-induced premature catagen development assessed with human hair follicle organ culture model
- Oil Body-Bound Oleosin-rhFGF-10: A Novel Drug Delivery System that Improves Skin Penetration to Accelerate Wound Healing and Hair Growth in Mice
- The role of aquaporins in polycystic ovary syndrome – A way towards a novel drug target in PCOS
- Lysocellin, a metabolite of the novel drug ‘alopestatin’, induces G1 arrest and prevents cytotoxicity induced by etoposide
- Natural products and their derivatives as candidate treatments for hair greying: from drug discovery to molecular mechanisms
- Hair Loss in a Hemodialysis Patient after Repetitive Use of the Antipruritic Drug Nalfurafine: Implications of Impaired Angiogenesis for Hair Loss
- The Interrelation Between Hirsutism and Androgen Hormone Levels as Well as Serum TNFΑ Concentrations
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
- An assessment of curcumin, curcumin spanlastics nanoparticles, and curcumin nanocrystals as possible drug delivery systems with antimicrobial, antioxidant, and antitumor activities